Heart Failure Clinical Trials
150 studies are recruiting for heart failure in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 3
-
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. The purpose of this clinical study is to f…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Advanced Cardiovascular, LLC, Alexander City, Alabama
- Locations
- 838 in total
- Run by
- Novo Nordisk A/S
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
The purpose of this research is to determine if two proteins in the blood are increased during acute heart failure. These two proteins are produced when the heart becomes dysfunctional and unable to contract normally. They may then be released into the blood and be detected by standard method in th…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Connecticut Health Center, Farmington, Connecticut
- Run by
- UConn Health
-
Alleviant ALLAY-HF Study
Prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFpEF/HFmrEF.
- Stage
- Not phased
- Ages
- 40 and older
- Site
- Pima Heart and Vascular, Tucson, Arizona
- Locations
- 93 in total
- Run by
- Alleviant Medical, Inc.
-
MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
The goal of this clinical trial is to evaluate the accuracy and feasibility of transdermal glomerular filtration rate (tGFR) assessment using relmapirazin (Lumitrace) and the MediBeacon tGFR system compared to plasma clearance measurement of GFR in adults with heart failure. The main question it ai…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Columbia University, New York, New York
- Run by
- MediBeacon
-
LVAD Conditioning for Cardiac Recovery
The purpose of this study is to investigate the potential recovery of heart function in end-stage heart failure patients supported with a Left Ventricular Assist Device (LVAD) through applying a myocardial conditioning protocol. During myocardial conditioning, LVAD speed is reduced gradually in ord…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Utah, Salt Lake City, Utah
- Run by
- STAVROS G DRAKOS
-
Improving Self-Care of Caregivers of Adults in Homecare With Heart Failure and Cognitive Impairment
This RCT design will enroll 256 informal caregivers (spouse/partner or child) of HHC patients with HF/CI and 60 patients with HF and mild to moderate CI (60 dyads). After collecting baseline data, we will block randomize the caregivers 1:1 to the ViCCY intervention or comparator group, stratifying …
- Stage
- Not phased
- Ages
- 18 to 101
- Site
- VNS Health, New York, New York
- Run by
- Visiting Nurse Service of New York
-
Study of the Progression of Chronic Cardiovascular Conditions
This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Prolaio, Chicago, Illinois
- Run by
- Prolaio
-
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
There are two primary goals of this multicenter clinical trial that combines an FDA device trial and a phase II drug trial in the same study cohort. These two goals are to: 1. To evaluate the safety and effectiveness of the Cardiohelp Device for VA-ECMO (heart-lung support) for up to 30 days of sup…
- Stage
- Phase 2
- Ages
- 0 to 16
- Site
- Lucile Packard Children's Hospital, Palo Alto, California
- Locations
- 5 in total
- Run by
- Stanford University
-
Cardiovascular Multimodality Imaging Study
Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk for cardiovascular disease and higher propensity for cardiovascular related mortality among Black and non-Hispanic White patients. Recently, …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Montefiore Health System, The Bronx, New York
- Run by
- Montefiore Medical Center
-
Inspiratory Muscle Training in HFpEF
This study is being done to determine how inspiratory muscle training impacts inspiratory muscle function during exercise in heart failure patients.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic in Rochester, Rochester, Minnesota
- Run by
- Mayo Clinic
-
Cardiac Power Output in Cardiogenic Shock Patients
The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients.
- Stage
- EARLY_Phase 1
- Ages
- 18 and older
- Site
- The University of Chicago, Chicago, Illinois
- Run by
- University of Chicago
-
Longitudinal Validation of CIRC Technologies
Cardiovascular disease is the leading cause of death worldwide. Advanced cardiovascular imaging using Magnetic Resonance Imaging (MRI) has proven to be effective in providing gold standard myocardial tissue characterization. Moreover, the intrinsic advantage of MRI's lack of exposure to ionizing ra…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Cleveland Clinic, Cleveland, Ohio
- Run by
- The Cleveland Clinic
-
Community-Informed Interventions for Equitable Congestive Heart Failure Management in Primary Care
The purpose of this study is to expand subject matter expertise and sustained capacity for equity-oriented care within the Advanced Care Ecosystem (ACE) by engaging patients, caregivers, community health workers (CHW), and care-team stakeholders in development work focused on adults living with con…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic, Rochester, Minnesota
- Run by
- Mayo Clinic
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Cedars-Sinai Medical Center, Los Angeles, California
- Run by
- Cedars-Sinai Medical Center
-
A Study to Evaluate Breathing Muscle Training in Cardiac Rehab
The purpose of this study is to understand if breathing muscle training combined with cardiac rehabilitation influences the blood flow and blood pressure response during exercise.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic in Rochester, Rochester, Minnesota
- Run by
- Mayo Clinic
-
Promoting Palliative Care for People With Heart Failure
This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic infor…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Yale New Haven Hospital Saint Raphael, New Haven, Connecticut
- Locations
- 2 in total
- Run by
- Yale University
-
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova
A randomized, single-blind intervention trial to test the comparative effectiveness of an electronic health record best practice advisory system that informs clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients with heart failure ve…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Inova Health System, Falls Church, Virginia
- Run by
- Inova Health Care Services
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients with heart failure and reduced ejection fraction (HFrEF) who are intolerant or ineligible to receive treatment with steroidal mineralocorticoid receptor antagonists (sMRA).
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- FIN-10004 Fairhope, AL Investigational Site, Fairhope, Alabama
- Locations
- 176 in total
- Run by
- Colorado Prevention Center
-
Care Transitions App for Patients With Multiple Chronic Conditions
The objective of this study is to widely implement and evaluate the Care Transitions App in a randomized controlled trial. The app the investigators designed for patients with multiple chronic conditions has four envisioned modules: 1) falls-reduction content, 2) a digital post-discharge transition…
- Stage
- Not phased
- Ages
- 55 and older
- Site
- Brigham and Women's Hospital, Boston, Massachusetts
- Run by
- Brigham and Women's Hospital
-
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
To determine feasibility of recruitment and tolerability of treatment with sacubitril-valsartan among adult age survivors of cancer diagnosed at or before age 39 who have stage B heart failure.
- Stage
- Phase 1
- Ages
- 18 to 120
- Site
- Virginia Commonwealth University, Richmond, Virginia
- Run by
- Virginia Commonwealth University
-
Project 4: ACHIEVE PATHFINDER
ACHIEVE-P4: PATHFINDER is a randomized, blinded clinical trial of portable air cleaners (PAC) provided at the time of hospital discharge to Heart Failure (HF) patients. It will be carried out at Henry Ford Hospitals. This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Henry Ford Health, Detroit, Michigan
- Run by
- Henry Ford Health System
-
The STOP-MED CTRCD Trial
Cancer therapy-related cardiac dysfunction (CTRCD) is when the heart's ability to pump oxygenated blood to the body is compromised. It is a side effect of cancer therapy which can occur as commonly as in 1 in 5 patients. When this occurs, heart failure medications are started to protect the heart f…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- Brigham and Women's Hospital, Boston, Massachusetts
- Locations
- 14 in total
- Run by
- Dinesh Thavendiranathan
-
UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF
This study will use polygenic scores, a tool which describes differences in genetics, to examine effectiveness of beta blocker medication in heart failure patients with ejection fraction of 41-50 percent. The study will also assess beta blockers' effect on the changes in left ventricular end-systol…
- Stage
- Not phased
- Ages
- 18 to 89
- Site
- Henry Ford Health, Detroit, Michigan
- Run by
- David Lanfear
-
18F-mFBG Imaging for Myocardial Sympathetic Innervation
This is a Phase 2 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an imaging agent for quantification of myocardial sympathetic innervation. The study will examine a group of stable patients with heart failure (HF) from ischemic cardiomyopathy. All subjects will have left ven…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- UT Health Houston, Houston, Texas
- Run by
- Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
-
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial). The study contains of 5 arms: NYHA II Cohort - To demonstrate saf…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- St. Joseph's Hospital and Medical Center, Phoenix, Arizona
- Locations
- 48 in total
- Run by
- Endotronix, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.